menu
    • menu

    Company profile for Aspen Neuroscience

    NEW Drugs in Dev: 1
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Summit for Stem Cell was founded in 2011 because of a desire from Parkinson patients to fund a stem cell-based therapy for their disease. Summit started as a small group of friends raising money for a cause they believed in and grew into a large organization with supporters all over the world. Summit funded the work in Jeanne Loring’s lab at The Scripps Research Institute to develop an autologous neuron replacement program. ...
    Summit for Stem Cell was founded in 2011 because of a desire from Parkinson patients to fund a stem cell-based therapy for their disease. Summit started as a small group of friends raising money for a cause they believed in and grew into a large organization with supporters all over the world. Summit funded the work in Jeanne Loring’s lab at The Scripps Research Institute to develop an autologous neuron replacement program. After years of successfully supporting and promoting this brilliant body of science, Summit helped found Aspen Neuroscience, Inc. in late 2018. The iPSC-based therapy has been transferred to Aspen Neuroscience, Inc.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aspen NeuroscienceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    10835 Road to the Cure, Ste. 100, San Diego, CA 92121
    Telephone
    Telephone
    +1 (858) 263-1222
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aspenneuroscience.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aspen-neuroscience/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AspenNeuro

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aspen's Parkinson's Cell Therapy Data Plant Seeds For Ph. 3
    Aspen's Parkinson's Cell Therapy Data Plant Seeds For Ph. 3

    18 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/aspens-one-year-data-parkinsons-cell-therapy-plants-seeds-ph-3-trial

    FIERCE BIOTECH
    18 Mar 2026
    Share Share
    Aspen Gets Sasineprocel as Nonproprietary Name for ANPD001
    Aspen Gets Sasineprocel as Nonproprietary Name for ANPD001

    12 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aspen-receives-adoption-of-sasineprocel-as-the-official-nonproprietary-naming-of-anpd001-its-investigational-autologous-cell-therapy-for-the-treatment-of-parkinsons-disease-302711623.html

    PR NEWSWIRE
    12 Mar 2026
    Share Share
    Aspen Neuroscience Names Lisa Johnson-Pratt as CCO, Revati as CMO
    Aspen Neuroscience Names Lisa Johnson-Pratt as CCO, Revati as CMO

    07 Jan 2026

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/aspen-neuroscience-appoints-chief-commercial-officer-lisa-johnson-pratt-md-and-welcomes-revati-shreeniwas-md-fccp-as-chief-medical-officer-to-accelerate-latestage-development-and-commercial-readiness-302654425.html

    PR NEWSWIRE BIO
    07 Jan 2026
    Share Share
    Aspen Adds $115M Series C To Grow Cell Therapy Ambitions
    Aspen Adds $115M Series C To Grow Cell Therapy Ambitions

    20 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/aspen-enriches-parkinsons-cell-therapy-trial-kite-backed-115m-series-c

    FIERCE BIOTECH
    20 Nov 2025
    Share Share
    Aspen Neuro Initiates Cohort 3 In Aspiro Trial For Anpd001
    Aspen Neuro Initiates Cohort 3 In Aspiro Trial For Anpd001

    25 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aspen-neuroscience-initiates-cohort-3-in-aspiro-phase-12a-trial-highlighting-commercial-formulation-of-anpd001-and-its-transformative-potential-for-parkinsons-disease-302566431.html

    PR NEWSWIRE
    25 Sep 2025
    Share Share
    Aspen Neuroscience Advances Cell Therapy for Parkinson's Disease
    Aspen Neuroscience Advances Cell Therapy for Parkinson's Disease

    10 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aspen-neuroscience-advances-the-automated-production-of-personalized-autologous-cell-therapy-for-parkinsons-disease-302345561.html

    PR NEWSWIRE
    10 Jan 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search